Dysmenorrhea, Endometrium Hyperplasia, Myoma, Uterine Bleeding, Dysfunctional, Uterine Bleeding Heavy
Conditions
Keywords
ulipristal acetate, myoma, leiomyoma, endometrial patterns, symptomatology
Brief summary
A prospective observational study on italian women undergoing ulipristal acetate (uPa) therapy for symptomatic myomas and its impact on symptomatology and moreover on myomas architecture. We also evaluate changes in the endometrial pattern of selected women.
Interventions
Evaluation of endometrial thickness; myoma size and volume
Sponsors
Study design
Eligibility
Inclusion criteria
* number of myomas from 1 to 4 * heavy menstrual bleeding * conservative treatment request
Exclusion criteria
* concurrent endometrial pathology * post-menopausal status * hepatic pathology * endocrine or metabolic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dysmenhorrea (VAS score) | 12 months |
| Endometrial thickess (mm) | 12 months |
| Myoma's diameter (mm) | 12 months |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Live birth rate (LBR) | 12 months | Live birth rate if women conceived spontaneously or through ARTs after treatment |
Countries
Italy